| Literature DB >> 31068756 |
Hiroki Teragawa1, Chikage Oshita1, Tomohiro Ueda1.
Abstract
A myocardial bridge (MB) is an anatomical abnormality of the coronary artery and is characterized by the systolic narrowing of the epicardial coronary artery caused by myocardial compression during systole. An MB is frequently observed on cardiac computed tomography or coronary angiography and generally appears to be harmless in the majority of patients. However, the presence of MB is reportedly associated with abnormalities of the cardiovascular system, including coronary artery diseases, arrhythmia, certain types of cardiomyopathy, and cardiac death, indicating that MB serves a pivotal role in the occurrence and/or development of such cardiovascular events. Recently, there has been an increasing interest in the coexistence of MB and coronary spasm in research due to opposing aspects regarding their treatments. For example, monotherapy using β-blockers, which are effective in patients with MB, may worsen symptoms in patients with coronary spasm. By contrast, nitroglycerin, which is an effective treatment option for coronary spasm, may worsen symptoms in patients with MB. This review focuses on the pathophysiology and diagnosis of MB and MB-related cardiovascular diseases, including coronary spasm, and on the treatment strategies for MB.Entities:
Keywords: coronary spasm; exertional angina; myocardial bridge; rest angina; vasospastic angina
Year: 2019 PMID: 31068756 PMCID: PMC6495429 DOI: 10.1177/1179546819846493
Source DB: PubMed Journal: Clin Med Insights Cardiol ISSN: 1179-5468
Figure 1.Possible mechanisms of the development of the myocardial bridge responsible for coronary artery disease, and favorable treatments based on the causes.
CAD indicates coronary artery disease; CCB, calcium channel blocker.
Figure 2.Coronary angiograms in a representative patient with myocardial bridge (MB) and coronary spasm. The patient experienced chest symptoms during exercise in the early morning only. Coronary angiography revealed a severe vasospasm provoked by intracoronary infusions of acetylcholine (indicated by arrows) (A) and the presence of MB at spastic segment (B: diastole, C: systole), which is indicated by arrows.
MB indicates myocardial bridge.
Studies showing the relationship between MB and coronary spasm.
| No. | Authors | Reference No. | Year | Main findings |
| 1 | Teragawa et al | 16 | 2003 | In 114 patients who had any chest symptoms, MB was one of predictors of presence of coronary spasm, on logistic regression analysis. In addition, the MB segment in response to acetylcholine was more constrictive, even in patients without coronary spasm. |
| 2 | Kim et al | 17 | 2008 | In 128 patients with typical angiographic MB, coronary vasoconstriction (>50%) to acetylcholine was observed more often than control patients (89.1% vs 35.1%), despite the absence of plaque at the MB segments on intravascular ultrasonographic study. |
| 3 | Saito et al | 18 | 2017 | In 392 patients who underwent spasm provocation test, LAD spasm was provoked more frequently in patients with MB. Multivariate regression analysis demonstrated that the length of MB and percent systolic compression of MB were significant predictors for provoked LAD spasm. |
| 4 | Nam et al | 19 | 2018 | In 812 patients with MB, coronary spasm was provoked in 59.1% of patients. The length of MB, percent systolic compression of MB, and reference diameter were associated with coronary spasm. Patients with MB and coronary spasm experienced recurrent angina more frequently during the 5-year follow-up. |
Abbreviations: LAD, left anterior descending coronary artery; MB, myocardial bridge.